Renzo Cescato - Concepedia

Concepedia

Author

Renzo Cescato

University of Bern

Also Known As

Cescato, Renzo, R Cescato, R. Cescato, Renzo Cescato

62

Publications

3.3K

Citations

26

H-Index

36

Concepts

All Affiliations

University of Bern University Hospital of Basel Salk Institute for Biological Studies Clayton Foundation Novartis (Switzerland)

RC

About

Renzo Cescato is an author at University of Bern specializing in medicine, pharmacology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Cell Biology	4	4	130
3	Engineering	3	3	624
4	Biochemistry	3	3	64
5	Natural Sciences	2	2	40

Renzo Cescato

×

43

Publications

3.3K

Citations

26

H-Index

	Year	Citations
Radiolabeled somatostatin receptor antagonists are preferable to agonists for<i>in vivo</i>peptide receptor targeting of tumors Mihaela Ginj, Hanwen Zhang, Beatrice Waser, Proceedings of the National Academy of Sciences EngineeringImmunologyPeptide SciencePharmacotherapyPeptide Therapeutics	2006	488
Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting Renzo Cescato, Berthold A. Nock, Anastasia Nikolopoulou, Journal of Nuclear Medicine	2008	289
PET of Somatostatin Receptor–Positive Tumors Using <sup>64</sup>Cu- and <sup>68</sup>Ga-Somatostatin Antagonists: The Chelate Makes the Difference Melpomeni Fani, Luigi Del Pozzo, K. Abiraj, Journal of Nuclear Medicine	2011	255
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours Rosalba Mansi, Xuejuan Wang, Flavio Forrer, European Journal of Nuclear Medicine and Molecular Imaging Tumor BiologyGrpr-positive TumoursDrug TargetingOncologyMedicine	2010	197
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. Renzo Cescato, Stefan Schulz, Beatrice Waser, PubMed	2006	185
Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid–Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides Rosalba Mansi, Xuejuan Wang, Flavio Forrer, Clinical Cancer Research	2009	172
Unexpected Sensitivity of sst<sub>2</sub> Antagonists to N-Terminal Radiometal Modifications Melpomeni Fani, Friederike Braun, Beatrice Waser, Journal of Nuclear Medicine	2012	163
Design and in Vitro Characterization of Highly sst<sub>2</sub>-Selective Somatostatin Antagonists Suitable for Radiotargeting Renzo Cescato, J. Érchegyi, Beatrice Waser, Journal of Medicinal Chemistry Vitro CharacterizationEngineeringEndocrine-related CancerMedicineTheranostics	2008	112
Highly Efficient In Vivo Agonist-Induced Internalization of sst<sub>2</sub> Receptors in Somatostatin Target Tissues Bea Waser, Maria‐Luisa Tamma, Renzo Cescato, Journal of Nuclear Medicine	2009	111
Bombesin Antagonist–Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor–Positive Tumors K. Abiraj, Rosalba Mansi, Maria‐Luisa Tamma, Journal of Nuclear Medicine	2011	106

Page 1